Australia’s active vaccine safety system

AstraZeneca COVID-19 vaccine safety data - People affected by cancer and transplant recipients

AstraZeneca COVID-19 vaccine

AusVaxSafety has been actively monitoring the short-term adverse event profile of COVID-19 vaccines used in Australia through post-vaccination safety surveys that allow vaccine recipients to report any adverse events they may have experienced at different intervals following vaccination. These surveys also allow individuals to report pre-existing medical conditions, allowing AusVaxSafety to capture COVID-19 vaccine safety data, specific to Australia, for people affected by cancer and transplant recipients.

AusVaxSafety captures COVID-19 vaccine safety data for the following cancer and transplant recipient population groups:

  • Cancer (not including blood or bone marrow cancer) diagnosed in the last 12 months
  • Blood cancer (e.g. leukaemia, lymphoma or myelodysplastic syndrome) diagnosed within the last 5 years
  • Organ transplant recipient on immune suppressive therapy or bone marrow transplant recipient in the last 2 years

AusVaxSafety has analysed the data collected from people who reported the above pre-existing conditions and have created infographics outlining the short-term adverse event profile for each group, including a comparison to the general population. These infographics provide individuals affected by cancer and transplant recipients with real-world information on what to expect following AstraZeneca COVID-19 vaccination and can be used when planning for COVID-19 vaccination.

News & events

All news & events

AusVaxSafety receives funding
from the Australian Government

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.

Copyright © 2022 AusVaxSafety. All rights reserved

vaccine

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.